Acarten 25 Tablet contains Acarbose 25mg, an oral antidiabetic agent used to manage postprandial hyperglycemia in type 2 diabetes. Acarbose works by inhibiting alpha-glucosidase enzymes in the intestines, delaying carbohydrate absorption and reducing blood sugar spikes after meals.
This tablet falls under the diabetes care segment, offering an effective solution for patients requiring adjunct therapy along with diet and lifestyle management. Its low-dose formulation allows easy titration for personalized treatment.
Acarten 25 Tablet is widely prescribed by endocrinologists, general physicians, hospitals, and clinics, making it a high-demand product for PCD pharma distribution. Its proven efficacy and safety profile enhance patient compliance and repeat prescriptions.
For PCD pharma franchise and B2B partners, Acarten 25 Tablet represents a profitable opportunity. Its inclusion in diabetes care portfolios, hospital demand, and growing patient population ensure steady business growth, making it ideal for domestic distribution, export, and third-party manufacturing.